ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Caroline Leopold

Caroline Leopold

Over the past 15 years, Caroline Leopold has secured grants for research and programs for public benefit. Among her specialties are NIH, HRSA, and national foundations. She currently works as a grants consultant and medical writer and in 2012 wrote more than proposals for about 150 million of available funding. For more information, contact Caroline Leopold at leopoldwritng@gmail.com

Follow Caroline Leopold: Website | Twitter |

Patient navigation may boost cancer survival, study finds

Patient navigation may boost cancer survival, study finds

October 8, 2012 3:31 pm by | 0 Comments

Helping people access doctors may save more lives from cancer is the conclusion of a study released today.George Washington researchers published results of a study that found patient navigation sped ... Read more
Suicide is on the rise while solutions remain elusive

Suicide is on the rise while solutions remain elusive

September 25, 2012 12:43 pm by | 0 Comments

Suicide is now the leading cause of death by injury in the United States, surpassing motor vehicle accidents as reported by the American Journal of Public Health. In an analysis ... Read more
CDC says high blood pressure is a public enemy in U.S.

CDC says high blood pressure is a public enemy in U.S.

September 6, 2012 1:06 pm by | 0 Comments

The U.S. Centers for Disease Control (CDC) reported on Tuesday in the weekly Mortality and Morbidity Report that 67 million people in the United States have high blood pressure and ... Read more
Stribild: High cost of new HIV drug may not be worth the benefit

Stribild: High cost of new HIV drug may not be worth the benefit

August 31, 2012 2:08 pm by | 1 Comments

Gilead Sciences announced on Monday that Stribild, a four-in-one combination HIV treatment in a single pill, received FDA approval. In clinical trials submitted to the FDA, the drug was found ... Read more
New data on trastuzumab emtansine (T-DM1) from EMILIA Phase III trial

New data on trastuzumab emtansine (T-DM1) from EMILIA Phase III trial

August 27, 2012 7:46 am by | 0 Comments

Genentech, a member of the Swiss pharmaceutical company Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced updated results from the Phase III EMILIA study, which showed that trastuzumab emtansine (T-DM1) ... Read more
Troubled state budgets unable to meet the AIDS crisis

Troubled state budgets unable to meet the AIDS crisis

August 8, 2012 5:54 pm by | 0 Comments

Yesterday, the Illinois Lottery Commission and the state’s Department of Public Health announced the rebirth of ’Red Ribbon Cash,’ an instant game lottery, which will raise an estimated $1 million ... Read more
Truvada benefits out of reach for many with HIV

Truvada benefits out of reach for many with HIV

July 28, 2012 1:49 pm by | 0 Comments

Debates raged at the 19th International AIDS Conference was held Washington, DC from July 22 to 27, on the latest news in HIV prevention and treatment research. The conference was ... Read more